FLSM
ORIC icon

Frazier Life Sciences Management’s Oric Pharmaceuticals ORIC Stock Holding History

Frazier Life Sciences Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,065,334
Closed -$10.8M – 52
2025
Q2 		$10.8M Sell
1,065,334
-344,859
-24% -$2.32M 0.43% 38
2025
Q1 		$7.87M Sell
1,410,193
-2,478,045
-64% -$21.7M 0.36% 33
2024
Q4 		$31.4M Sell
3,888,238
-254,617
-6% -$2.34M 1.3% 20
2024
Q3 		$42.5M Hold
4,142,855
– – 1.7% 20
2024
Q2 		$29.3M Hold
4,142,855
– – 1.37% 22
2024
Q1 		$57M Buy
4,142,855
+2,000,000
+93% +$23.8M 2.4% 13
2023
Q4 		$19.7M Hold
2,142,855
– – 1.05% 26
2023
Q3 		$13M Hold
2,142,855
– – 0.86% 30
2023
Q2 		$16.6M Buy
+2,142,855
New +$12.2M 0.99% 27

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return